Works matching IS 00912700 AND DT 2025 AND VI 65 AND IP 3

Results: 13

Efficacy and Safety of SGLT‐2 Inhibitors in Acute Myocardial Infarction: A Systematic Review and Meta‐Analysis.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 303, doi. 10.1002/jcph.6149

By:

Asham, Hila;
Ghaffari, Samad;
Taban‐Sadeghi, Mohammadreza;
Entezari‐Maleki, Taher

Publication type:

Article

Dried Blood Spots Sampling and Population Pharmacokinetic Modeling for Dosing Optimization of Piperacillin in Chinese Neonates.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 361, doi. 10.1002/jcph.6145

By:

Li, Pei;
Chen, Quanyao;
Chen, Yao;
Zheng, Zhi;
Zhao, Xiaoyan;
Chen, Huayan;
Liu, Qian;
Xie, Feifan

Publication type:

Article

Sentinel Dosing—Time for a Risk‐Based Approach?

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 267, doi. 10.1002/jcph.6167

By:

Bonate, Peter L.;
Rogge, Mark;
Gries, Jean‐Michel;
Prokopienko, Alexander J.;
Pai, Sudhakar M.

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 261, doi. 10.1002/jcph.70013
Publication type:: Article

Training the Next Generation of Pediatric Clinical Pharmacologists: Insights and Trainee Perspectives Over 10 Years.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 389, doi. 10.1002/jcph.6155

By:

Randell, Rachel L.;
Gelineau‐Morel, Rose;
Thomas, Sydney;
Gonzalez, Daniel;
Leeder, J. Steven;
Hornik, Christoph P.

Publication type:

Article

Exposure‐Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISM.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 350, doi. 10.1002/jcph.6152

By:

Lindauer, Andreas;
Snoeck, Eric;
Laveille, Christian;
Ayani, Ignacio;
de Monasterioguren, Lourdes Ochoa Díaz;
Almendros, Marcos;
Martínez‐González, Javier;
Anta, Lourdes;
Gutierro, Ibón

Publication type:

Article

Pharmacological Management of Sleep–Wake Disturbances in Delirium.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 285, doi. 10.1002/jcph.6151

By:

Levinsohn, Erik A.;
Radhakrishnan, Varsha;
Euting, Haley;
Kaplan, Gary B.

Publication type:

Article

Addressing Drug–Drug Interaction Knowledge Gaps at the Time of Approval: An Analysis of FDA Postmarketing Requirements and Commitments from 2009 to 2023.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 378, doi. 10.1002/jcph.6142

By:

Ridge, Sarah;
Yang, Xinning;
Madabushi, Rajanikanth;
Ramamoorthy, Anuradha

Publication type:

Article

Exploring the Impact of Developmental Clearance Saturation on Propylene Glycol Exposure in Adults and Term Neonates Using Physiologically Based Pharmacokinetic Modeling.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 272, doi. 10.1002/jcph.6150

By:

Olafuyi, Olusola;
Michelet, Robin;
Garle, Michael;
Allegaert, Karel

Publication type:

Article

Inflammation Decreases Ciclosporin Metabolism in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 328, doi. 10.1002/jcph.6141

By:

Malnoë, David;
Bories, Mathilde;
Pierre‐Jean, Morgane;
Marchand, Tony;
Le Corre, Pascal

Publication type:

Article

Exposure–Response Analysis of Tofacitinib in Active Psoriatic Arthritis: Results from Two Phase 3 Studies.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 369, doi. 10.1002/jcph.6147

By:

Menon, Sujatha;
Shoji, Satoshi;
Tsuchiwata, Shinichi;
Fallon, Lara;
Kanik, Keith

Publication type:

Article

Subclinical Hyperthyroidism Enhances Gonadotropin‐Lowering Effects of Metformin in Postmenopausal Women.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 318, doi. 10.1002/jcph.6144

By:

Krysiak, Robert;
Kowalcze, Karolina;
Okopień, Bogusław

Publication type:

Article

Pharmacokinetics and Safety of a Novel Extended‐Release Microsphere Formulation of Risperidone in Patients with Schizophrenia or Schizoaffective Disorder.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 3, p. 340, doi. 10.1002/jcph.6143

By:

Walling, David P.;
Dong, Ying;
Litman, Robert;
Wang, Wenyan;
Liu, Chunli;
Tai, Joe;
Liu, Pinglan;
Shi, Yanan;
Liu, Wanhui;
Fu, Fenghua;
Sun, Kaoxiang

Publication type:

Article